Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the companys Annual Report on Form 10-K for the year ended December 31, 2023 and the companys other filings with the Securities and Exchange Commission (SEC) available at the SECs Internet site (www.sec.gov)
The Gastrointestinal Symphony The most frequently reported side effects center around digestive discomfort: Nausea : Affects a significant portion of users, particularly during the initial weeks of treatment or after dose increases Vomiting : Can occur alongside nausea, though typically less common Diarrhea : Ranges from mild inconvenience to more disruptive episodes These gastrointestinal symptoms often diminish as the body adjusts to the medication, though some patients may experience persistent issues requiring dose adjustments or discontinuation
Therefore, clinicians must stay informed about evolving guidelines and best practices
Currently, only two RCTs have reported data surrounding the effectiveness of pharmacological treatment in adults with EOT2D in sub-analyses of larger RCTs [65,66]
US$ 20.86
US$ 23.36
US$ 23.03
US$ 27.92
US$ 21.97
US$ 20.59
US$ 24.37
US$ 24.53
US$ 21.91
